High-Dose Eylea’s Improved Durability Could Protect Regeneron’s Market Share

As Roche’s Vabysmo Mounts Threat

 
• By Ayisha Sharma
View inside human eye disorders - showing retina, optic nerve and macula.
Eylea Biosimilars Could Reach The Market In 2024 • Source: Shutterstock

More from Sensory

More from Therapeutic Category